These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Von Willebrand factor in inflammation and heart failure: beyond thromboembolic and bleeding risk. Ministrini S; Tirandi A Eur Heart J; 2024 Oct; 45(37):3868-3870. PubMed ID: 39193812 [No Abstract] [Full Text] [Related]
3. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Sbarouni E; Bradshaw A; Andreotti F; Tuddenham E; Oakley CM; Cleland JG Am Heart J; 1994 Mar; 127(3):607-12. PubMed ID: 8122609 [TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921 [TBL] [Abstract][Full Text] [Related]
5. Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen. Goldsmith IR; Blann AD; Patel RL; Lip GY Am J Cardiol; 2001 Jan; 87(1):107-10, A9. PubMed ID: 11137845 [TBL] [Abstract][Full Text] [Related]
6. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. Lip GY; Conway DS J Am Coll Cardiol; 2001 Dec; 38(7):2133-5. PubMed ID: 11738328 [No Abstract] [Full Text] [Related]
7. [Thromboembolism and blood coagulation in congestive heart failure]. Serbin VI; Muratov AA Pediatriia; 1991; (2):92-7. PubMed ID: 2057304 [No Abstract] [Full Text] [Related]
8. von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support. Nascimbene A; Hilton T; Konkle BA; Moake JL; Frazier OH; Dong JF J Heart Lung Transplant; 2017 Apr; 36(4):477-479. PubMed ID: 28325436 [No Abstract] [Full Text] [Related]
9. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage. Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775 [TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor disruption and continuous-flow circulatory devices. Proudfoot AG; Davidson SJ; Strueber M J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118 [TBL] [Abstract][Full Text] [Related]
11. A new spin on acquired von Willebrand factor deficiency during continuous-flow left ventricular assist device support. Toole JM J Thorac Cardiovasc Surg; 2015 Jan; 149(1):289-90. PubMed ID: 25312230 [No Abstract] [Full Text] [Related]
12. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG Am J Cardiol; 1995 Sep; 76(7):453-8. PubMed ID: 7653443 [TBL] [Abstract][Full Text] [Related]
13. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients? Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Chin BS; Blann AD; Gibbs CR; Chung NA; Conway DG; Lip GY Eur J Clin Invest; 2003 Nov; 33(11):941-8. PubMed ID: 14636296 [TBL] [Abstract][Full Text] [Related]
15. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106 [TBL] [Abstract][Full Text] [Related]
16. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin. Chong AY; Lip GY; Freestone B; Blann AD Eur J Heart Fail; 2006 Mar; 8(2):167-72. PubMed ID: 16185922 [TBL] [Abstract][Full Text] [Related]
17. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation. Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770 [TBL] [Abstract][Full Text] [Related]
18. [Changes of Willebrand factor level in blood plasma of cancer patients and its role in hemostatic disturbances]. Danilova AB; Papaian LP; Okulov VB Vopr Onkol; 1996; 42(5):26-30. PubMed ID: 9064898 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes. Kistorp C; Chong AY; Gustafsson F; Galatius S; Raymond I; Faber J; Lip GY; Hildebrandt P Eur J Heart Fail; 2008 Apr; 10(4):380-7. PubMed ID: 18343722 [TBL] [Abstract][Full Text] [Related]
20. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center. Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]